Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies
Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies
Recruiting · NCT06351527 · Registry updated 2025-06-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies | Mature B-cell Malignancies | Recruiting | Phase 1 | 2025-06-19 | NCT06351527 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| InnoCare Pharma Inc. | 3 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| BRCR Medical Center | Plantation | United States | 6 |
| Clinical Research Alliance | Westbury | United States | 14 |
| CNE CCOHTPC of Cherkasy Regional Council | Cherkasy | Ukraine | 2 |
| CNE"City Clin Hosp#4"of Dnipro City Council | Dnipro | Ukraine | 1 |
| Med Center 'Ok!Clinic+' of International Institute of Clinical Trials LLC | Kyiv | Ukraine | 1 |
| Medical Center of Limited Liability Company Arensia Exploratory Medicine | Kyiv | Ukraine | 1 |
| Pan American Center for Oncology Trials | San Juan | Puerto Rico | 2 |
| SI Institute of Blood Pathology and Transfusion Medicine of AMSU | Lviv | Ukraine | 1 |